Pfizer ABRYSVO® Post-Authorisation Safety Study – Hepatically and renally impaired
The purpose of this study is to assess the safety profile of the Pfizer RSV vaccine in renally and hepatically impaired older adults.
Pfizer/BioNTech Comirnaty® Post-Authorisation Safety Study
The primary aim of this study was to determine whether there is an increased risk of AESI after receiving the Pfizezr/BioNTech COVID-19 vaccine.
Pfizer/BioNTech Comirnaty® myocarditis and pericarditis study
The aim of this study is to characterise the clinical course of myocarditis and/or pericarditis diagnosed after receiving the Pfizer-BioNTech COVID-19 vaccine
Pfizer/BioNTech Comirnaty® bivalent Post-Authorisation Safety Study
The aim of this study is to assess whether there is an increased risk of AESI after receiving the bivalent Pfizer/BioNTech COVID-19 vaccine.
Moderna Spikevax® myocarditis and pericarditis study
The primary objective of this study is to identify risk factors for myocarditis and pericarditis after vaccination with the Moderna COVID-19 vaccine, as well as to characterise the clinical course […]
Moderna Spikevax® Post-Authorisation Safety Study
The primary objective of this study is to assess whether vaccination with the Moderna COVID-19 vaccine is associated with increased rates of AESI in the general population, with a secondary […]
Moderna Spikevax® Post-Authorisation Safety Study – Pregnancy
The primary objective of this study is to assess whether there is a higher risk of pregnancy and/or neonatal complications or adverse outcomes after exposure to the Moderna COVID-19 vaccine, […]
Janssen Jcovden® Post-Authorisation Safety Study
The first aim of the study was to conduct a feasibility assessment on a safety evaluation study on the Janssen COVID-19 vaccine, then to assess the risk of developing AESI […]
AstraZeneca AZD1222 Post-Authorisation Safety Study
This study aimed to evaluate the incidence and relative risk of AESI after receiving the AstraZeneca COVID-19 vaccine.
(Early) COVID-19 Vaccine Monitor – cohort event monitoring via primary and secondary data collection
This study aimed to monitor AESI prior and following COVID-19 vaccination, in order to estimate incidence rates and pick up signals.